Advertisement

Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice

      Abstract

      It has been demonstrated that hyperhomocysteinemia (HHcy) accelerates atherosclerosis in apolipoprotein E-deficient (apoE−/−) mice. In this study, vitamin-defined chow diets were used to induce HHcy in apoE−/− mice in an attempt to identify possible pathogenic pathways. Six-week-old female apoE−/− mice were divided into seven groups: vitamin-defined purified chow diet alone (control), or same diet supplemented with either d,l-homocysteine (↑Hcy) or l-homocystine (↑Hcy–Hcy), or diet high in l-methionine (↑Met), or diet high in B-vitamins (↑vitamin), or diets deficient in folate (↓folate) or vitamin B6 (↓B6). Eighteen weeks later, plasma total homocysteine (tHcy), lipids and atherosclerotic plaque burden (aortic root, aortic arch, and brachiocephalic trunk) were measured. tHcy levels were similar in the ↑vitamin, ↓folate, ↓B6 and control groups (9.2–10.1 μmol/l, NS), but elevated mildly in the ↑Hcy–Hcy group (16.1 μmol/l) and moderately in the ↑Met and ↑Hcy groups (53.6 and 51.5 μmol/l, respectively). Mice in the latter two groups had significantly more atherosclerosis in the aortic root. Although B vitamin-supplementation failed to lower tHcy levels, mice had less atherosclerosis in the aortic arch. In summary, dietary methionine and homocysteine, but not homocystine, enhanced the development of atherosclerosis. Supplementation with B vitamins appeared to confer homocysteine-independent protection against atherosclerosis. These results suggest that (1) there may be a threshold level below which homocysteine is not atherogenic; (2) the atherogenic effect of HHcy may be mediated via an intracellular pathway; and/or (3) the anti-atherogenic effect of B vitamins in normohomocysteinemic mice is independent of tHcy levels.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Eikelboom J.W.
        • Lonn E.
        • Genest Jr., J.
        • Hankey G.
        • Yusuf S.
        Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.
        Ann. Intern. Med. 1999; 131: 363-375
        • Zhou J.
        • Moller J.
        • Danielsen C.C.
        • Bentzon J.
        • Ravn H.B.
        • Austin R.C.
        • et al.
        Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice.
        Arterioscler. Thromb. Vasc. Biol. 2001; 21: 1470-1476
        • Hofmann M.A.
        • Lalla E.
        • Lu Y.
        • Gleason M.R.
        • Wolf B.M.
        • Tanji N.
        • et al.
        Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model.
        J. Clin. Invest. 2001; 107: 675-683
        • Lentz S.R.
        Does homocysteine promote atherosclerosis?.
        Arterioscler. Thromb. Vasc. Biol. 2001; 21: 1385-1386
        • Selhub J.
        • Jacques P.F.
        • Wilson P.W.
        • Rush D.
        • Rosenberg I.H.
        Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.
        J. Am. Med. Assoc. 1993; 270: 2693-2698
        • Robinson K.
        • Arheart K.
        • Refsum H.
        • Brattstrom L.
        • Boers G.
        • Ueland P.
        • et al.
        Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group.
        Circulation. 1998; 97: 437-443
        • Graham I.M.
        • Daly L.E.
        • Refsum H.M.
        • Robinson K.
        • Brattstrom L.E.
        • Ueland P.M.
        • et al.
        Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.
        J. Am. Med. Assoc. 1997; 277: 1775-1781
        • Verhoef P.
        • Meleady R.
        • Daly L.E.
        • Graham I.M.
        • Robinson K.
        • Boers G.H.
        Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group.
        Eur. Heart. J. 1999; 20: 1234-1244
        • Ubbink J.B.
        • Vermaak W.J.
        • van der Merwe A.
        • Becker P.J.
        • Delport R.
        • Potgieter H.C.
        Vitamin requirements for the treatment of hyperhomocysteinemia in humans.
        J. Nutr. 1994; 124: 1927-1933
        • Rimm E.B.
        • Willett W.C.
        • Hu F.B.
        • Sampson L.
        • Colditz G.A.
        • Manson J.E.
        • et al.
        Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women.
        J. Am. Med. Assoc. 1998; 279: 359-364
        • Yap S.
        • Naughten E.R.
        • Wilcken B.
        • Wilcken D.E.
        • Boers G.H.
        Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.
        Semin. Thromb. Hemost. 2000; 26: 335-340
        • Bellamy M.F.
        • McDowell I.F.
        • Ramsey M.W.
        • Brownlee M.
        • Newcombe R.G.
        • Lewis M.J.
        Oral folate enhances endothelial function in hyperhomocysteinaemic subjects.
        Eur. J. Clin. Invest. 1999; 29: 659-662
        • Verhaar M.C.
        • Wever R.M.
        • Kastelein J.J.
        • van Loon D.
        • Milstien S.
        • Koomans H.A.
        • et al.
        Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial.
        Circulation. 1999; 100: 335-338
        • Verhaar M.C.
        • Rabelink T.J.
        Future for folates in cardiovascular disease.
        Eur. J. Clin. Invest. 1999; 29: 657-658
        • Graham I.M.
        • O'Callaghan P.
        The role of folic acid in the prevention of cardiovascular disease.
        Curr. Opin. Lipidol. 2000; 11: 577-587
        • Reeves P.G.
        • Nielsen F.H.
        • Fahey Jr., G.C.
        AIN93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc writing committee on the reformulation of the AIN76-A rodent diet.
        J. Nutr. 1993; 123: 1935-1951
        • Møller J.
        • Rasmussen K.
        Homocysteine in plasma: stabilization of blood samples with fluoride.
        Clin. Chem. 1995; 41: 758-759
        • Paigen B.
        • Morrow A.
        • Holmes P.A.
        • Mitchell D.
        • Williams R.A.
        Quantitative assessment of atherosclerotic lesions in mice.
        Atherosclerosis. 1987; 68: 231-240
        • Daugherty A.
        • Pure E.
        • Delfel-Butteiger D.
        • Chen S.
        • Leferovich J.
        • Roselaar S.E.
        • et al.
        The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E−/− mice.
        J. Clin. Invest. 1997; 100: 1575-1580
        • Bentzon J.F.
        • Skovenborg E.
        • Hansen C.
        • Moller J.
        • de Gaulejac N.S.
        • Proch J.
        • et al.
        Red wine does not reduce mature atherosclerosis in apolipoprotein E-deficient mice.
        Circulation. 2001; 103: 1681-1687
        • National Research Council
        Nutrient requirements of laboratory animals. 4th revised ed. National Academy Press, Washington, DC1995
        • Lentz S.R.
        • Erger R.A.
        • Dayal S.
        • Maeda N.
        • Malinow M.R.
        • Heistad D.D.
        • et al.
        Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice.
        Am. J. Physiol. Heart Circ. Physiol. 2000; 279: H970-H975
        • Werstuck G.H.
        • Lentz S.R.
        • Dayal S.
        • Hossain G.S.
        • Sood S.K.
        • Shi Y.Y.
        • et al.
        Homocysteine-induced endiplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways.
        J. Clin. Invest. 2001; 107: 1263-1273
        • Starkebaum G.
        • Harlan J.M.
        Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.
        J. Clin. Invest. 1986; 77: 1370-1376
        • Loscalzo J.
        The oxidant stress of hyperhomocyst(e)inemia.
        J. Clin. Invest. 1996; 98: 5-7
        • Eberhardt R.T.
        • Forgione M.A.
        • Cap A.
        • Leopold J.A.
        • Rudd M.A.
        • Trolliet M.
        • et al.
        Endothelial cell dysfunction in a murine model of mild hyperhomocyst(e)inemia.
        J. Clin. Invest. 2000; 106: 483-491
        • Jacobsen D.W.
        Hyperhomocysteinemia and oxidative stress: time for a reality check?.
        Arterioscler. Thromb. Vasc. Biol. 2000; 20: 1182-1184
        • Verhaar M.C.
        • Wever R.M.
        • Kastelein J.J.
        • van Dam T.
        • Koomans H.A.
        • Rabelink T.J.
        5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia.
        Circulation. 1998; 97: 237-241
        • Verhaar M.C.
        • Stroes E.
        • Rabelink T.J.
        Folates and cardiovascular disease.
        Arterioscler. Thromb. Vasc. Biol. 2002; 22: 6-13
        • Nakashima Y.
        • Plump A.S.
        • Raines E.W.
        • Breslow J.L.
        • Ross R.
        ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
        Arterioscler. Thromb. 1994; 14: 133-140
        • Reddick R.L.
        • Zhang S.H.
        • Maeda N.
        Atherosclerosis in mice lacking apoE. Evaluation of lesional development and progression.
        Arterioscler. Thromb. 1994; 14: 141-147
        • Falk E.
        • Fuster V.
        Atherogenesis and its determinants.
        in: Fuster V. Alexander R.W. O'Rourke R.A. Roberts R. King S.B. Wellens H.J.J. Hurst's the heart. 10th ed. McGraw-Hill, New York2001 (chapter 35)
        • Palinski W.
        • Napoli C.
        • Reaven P.D.
        Mouse models of atherosclerosis.
        in: Simon D.I. Rogers C. Vascular disease and injury: preclinical research. Humana Press, Totowa2001 (chapter 12)